SCHEMBL3797120

SCHEMBL3797120

CCC(N)C(CO)(CO)S(=O)(=O)O

nearest known ligand 0.36

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
TP53 P04637 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21496249 0.84 TP53 (0.33) TP53
SCHEMBL708336 0.82 TP53 (0.30) TP53
Sulfuric Acid SCHEMBL28103676 0.70 TP53 (0.48) TP53
SCHEMBL12489483 0.69
SCHEMBL28437230 0.68 TP53 (0.35) TP53
Sulfuric Acid SCHEMBL1343066 0.68 TP53 (0.46) TP53
Sulfuric Acid SCHEMBL5883810 0.68 TP53 (0.46) TP53
Sulfuric Acid SCHEMBL27693648 0.68 TP53 (0.58) TP53
Sulfuric Acid SCHEMBL29043936 0.67 TP53 (0.41) TP53
Sulfuric Acid SCHEMBL29043937 0.67 TP53 (0.41) TP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 29 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020146720-A1 LIGNIN SOLVATION USING AQUEOUS BIOLOGICALLY COMPATIBLE BUFFERS UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INCORPORATED (US) 2020-07-16 WO claimed
EP-3426718-A1 METHODS OF FORMING IONICALLY CROSS-LINKED GELS NORDOVO BIOSCIENCES AS (NO) 2019-01-16 EP claimed
WO-2017153947-A1 METHODS OF FORMING IONICALLY CROSS-LINKED GELS NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY (NO) 2017-09-14 WO claimed
EP-2580201-A2 TRANSITION METAL-CATALYZED PROCESSES FOR THE PREPARATION OF N-ALLYL COMPOUNDS AND USE THEREOF Rhodes Technologies (US) 2013-04-17 EP claimed
WO-2011154827-A2 TRANSITION METAL-CATALYZED PROCESSES FOR THE PREPARATION OF N-ALLYL COMPOUNDS AND USE THEREOF RHODES TECHNOLOGIES (US) 2011-12-15 WO claimed
EP-3927783-A1 INK COMPOSITION Hewlett-Packard Development Company, L.P. (US) 2021-12-29 EP disclosed
WO-2021150198-A1 INK COMPOSITION HEWLETT-PACKARD DEVELOPMENT COMPANY, L.P. (US) 2021-07-29 WO disclosed
EP-3658632-A1 INKJET PRE-TREATMENT FLUID FOR DYE SUBLIMATION PRINTING Hewlett-Packard Development Company, L.P. (US) 2020-06-03 EP disclosed
EP-3658633-A1 DYE SUBLIMATION INK THERMAL INKJET PRINTING METHOD Hewlett-Packard Development Company, L.P. (US) 2020-06-03 EP disclosed
EP-3658635-A1 CYAN THERMAL INKJET DYE SUBLIMATION INKS Hewlett-Packard Development Company, L.P. (US) 2020-06-03 EP disclosed
EP-3426718-A1 METHODS OF FORMING IONICALLY CROSS-LINKED GELS NORDOVO BIOSCIENCES AS (NO) 2019-01-16 EP disclosed
WO-2018157248-A1 METHOD FOR THE ENZYMATIC SACCHARIFICATION OF A POLYSACCHARIDE THE ROYAL INSTITUTION FOR THE ADVANCEMENT OF LEARNING/MCGILL UNIVERSITY (CA) 2018-09-07 WO disclosed
WO-2012173694-A1 IONIC LIQUID CONTAINING SULFONATE IONS FLUIDIC, INC. (US) 2012-12-20 WO disclosed
WO-2012080891-A1 ANTI-NOTCH-1 ANTIBODIES RINAT NEUROSCIENCE CORP. (US) 2012-06-21 WO disclosed
WO-2012080926-A2 ANTI-NOTCH1 ANTIBODIES WYETH LLC (US) 2012-06-21 WO disclosed
EP-2231705-A2 TREATMENT OF INTERSTITIAL CYSTITIS Pfizer Limited (GB) 2010-09-29 EP disclosed
WO-2009077993-A2 TREATMENT OF INTERSTITIAL CYSTITIS PFIZER LIMITED (GB) 2009-06-25 WO disclosed
EP-0762828-A4 METHOD AND REAGENT SYSTEM FOR THE IMPROVED DETERMINATION OF WHITE BLOOD CELL SUBPOPULATIONS CARVER EDWARD LAWRENCE JR (US) 2002-03-20 EP disclosed
EP-0762828-A1 METHOD AND REAGENT SYSTEM FOR THE IMPROVED DETERMINATION OF WHITE BLOOD CELL SUBPOPULATIONS Carver, Edward Lawrence, Jr. (US) 1997-03-19 EP disclosed
WO-1995032622-A1 METHOD AND REAGENT SYSTEM FOR THE IMPROVED DETERMINATION OF WHITE BLOOD CELL SUBPOPULATIONS CDC TECHNOLOGIES INC (US) 1995-12-07 WO disclosed